Skip to main content

Press releases 1 hit

Investment strategies of corporate venture capital in life science industry revealed

Press releases   •   Dec 14, 2011 09:34 UTC

The US continues to dominate; most venture capital goes to drug discovery platforms and the most successful companies in need of venture capital are those who most clearly fit in to investors' strategy. Despite a leading R&D position, Swedish life science companies must improve international relations to succeed in attracting investments. This emerged in a new report on corporate venture capital.

News 1 hit

Decision making process of VC's uncovered

News   •   Nov 14, 2011 09:26 UTC

What makes pharmaceutical giants, like AstraZeneca or Johnson & Johnson, want to buy a smaller player and what factors are they looking at? Two researchers at the Karolinska Institute in Stockholm have studied which parameters corporate venture capitalists (CVCs) consider when evaluating a start-up.

Documents 1 hit

Investment criteria of corporate venture capital in life science industry

The US continues to dominate; most venture capital goes to drug discovery platforms and the most successful companies in need of venture capital are those who most clearly fit in to investors' strategy. Despite a leading R&D position, Swedish life science companies must improve international relations to succeed in attracting investments. This emerged in a new report on corporate venture capital.